@article{bd537b77d1cc42fa8ce7f62f50fb889a,
title = "A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome)",
abstract = "Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203. Plain language summary available online",
keywords = "QUALITY-OF-LIFE, CARCINOMA SYNDROME, DOUBLE-BLIND, OCULAR MANIFESTATIONS, GERMLINE MUTATIONS, HEDGEHOG PATHWAY, TUMOR, SUFU, RISK, MEDULLOBLASTOMA",
author = "B.J.A. Verkouteren and B. Cosgun and M.G.H.C. Reinders and P.A.W.K. Kessler and R.J. Vermeulen and M. Klaassens and S. Lambrechts and {van Rheenen}, J.R. and {van Geel}, M. and M. Vreeburg and K. Mosterd",
note = "Funding Information: sources None.We are very grateful to the patients{\textquoteright} representatives and the patient carer representatives for their input into this guideline. Furthermore, we are very grateful to L. Gijezen, S.M. Koudijs, and T. van Gorp for their contribution to this guideline.",
year = "2022",
month = feb,
doi = "10.1111/bjd.20700",
language = "English",
volume = "186",
pages = "215--226",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Oxford University Press",
number = "2",
}